Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
Status: Recruiting
Location: See all (8) locations...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a normal course of their medical management or diagnostic work-up for suspected or confirmed cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Able and willing to provide informed consent for participation
• Age ≥18 years at time of consent.
• Have a suspected or confirmed cancer diagnosis that is to be evaluated by means of a biopsy.
• Subjects who are newly diagnosed or have suspected cancer must be treatment-naïve at the time of biopsy. All other subjects should have the biopsy performed before starting their next line of treatment.
Locations
United States
Arkansas
Mercy Hospital - FTS
RECRUITING
Fort Smith
Maryland
Frederick Health Hospital
RECRUITING
Frederick
Missouri
Mercy Hospital - SPG
RECRUITING
Springfield
Mercy Hospital - South
RECRUITING
St Louis
Mercy Hospital -STL
RECRUITING
St Louis
Oklahoma
Mercy Hospital - OKC
RECRUITING
Oklahoma City
Texas
JPS Health Network
RECRUITING
Forth Worth
Baylor Scott and White Biorepository
NOT_YET_RECRUITING
Temple
Time Frame
Start Date: 2025-04-14
Estimated Completion Date: 2038-04
Participants
Target number of participants: 2000
Treatments
Study Population
Adults aged 18 years or older, who are able and willing to provide written informed consent, have a suspected or confirmed cancer diagnosis and will be undergoing a biopsy or similar procedure to obtain tumor tissue as a normal course of their medical management or diagnostic work-up.
Related Therapeutic Areas
Sponsors
Leads: Elephas